![](https://webarchive.library.unt.edu/eot2008/20090509190219im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20090509190219im_/http://www.cancer.gov/images/spacer.gif)
dendritic cell-CEA peptide vaccine A cancer vaccine consisting of dendritic cells harvested from a patient with cancer and pulsed or transduced with a peptide fragment of carcinoembryonic antigen (CEA), a tumor-associated antigen expressed by a wide range of cancers. When the altered dendritic cells are returned to the patient, they may stimulate the host immune system to mount a cytotoxic T-lymphocyte immune response against tumor cells expressing CEA. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)
![](https://webarchive.library.unt.edu/eot2008/20090509190219im_/http://www.cancer.gov/images/spacer.gif)
Synonyms: | ![](https://webarchive.library.unt.edu/eot2008/20090509190219im_/http://www.cancer.gov/images/spacer.gif) | CEA peptide-pulsed DC vaccine CEA peptide-pulsed dendritic cell vaccine Dendritic cell-carcinoembryonic antigen peptide vaccine | | ![](https://webarchive.library.unt.edu/eot2008/20090509190219im_/http://www.cancer.gov/images/spacer.gif) |
![](https://webarchive.library.unt.edu/eot2008/20090509190219im_/http://www.cancer.gov/images/spacer.gif)
![](https://webarchive.library.unt.edu/eot2008/20090509190219im_/http://www.cancer.gov/images/gray_spacer.gif)
![](https://webarchive.library.unt.edu/eot2008/20090509190219im_/http://www.cancer.gov/images/spacer.gif)
|
![](https://webarchive.library.unt.edu/eot2008/20090509190219im_/http://www.cancer.gov/images/spacer.gif) |